Latest Report on Breast Cancer - Identifying and Commercializing First-in-Class Innovation

ResearchMoz.us include new market research report " Breast Cancer - Identifying and Commercializing First-in-Class Innovation: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape.

View Full Report with TOC at: http://www.researchmoz.us/frontier-pharma-breast-cancer-identifying-and-commercializing-first-in-class-innovation-report.html

Alignment of First-in-Class Molecular Target with Disease Causation

One of the key trends in oncology and in breast cancer in particular over the last decade is the clinical and commercial impact of targeted therapies designed to target proteins in signaling pathways that are frequently mutated in a significant proportion of the patient population. By aligning the molecular targets for therapeutic intervention with disease causation and/or propagation, these therapies limit the systemic cytotoxic effects whilst inhibiting tumor-promoting signaling pathways. Such strategies thereby typically achieve superior efficacy and safety profiles.

Scope:-

The report analyzes innovation in breast cancer, in the context of the overall pipeline and current market landscape. In addition, it analyzed the deals landscape surrounding first-in-class products in breast cancer, and pinpoints opportunities for in-licensing. The report covers and includes

A brief introduction to breast cancer, including symptoms, pathophysiology, and overview of pharmacotherapy and treatment algorithms.

The changing molecular target landscape between market and pipeline and particular focal points of innovation in the pipeline.

Comprehensive review of the pipeline for first-in-class therapies, analyzed on the basis of stage of...